Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$884M |
| 2 |
Tesla
TSLA
|
+$641M |
| 3 |
Visa
V
|
+$520M |
| 4 |
Amazon
AMZN
|
+$457M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.14B |
| 2 |
Apple
AAPL
|
+$916M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$907M |
| 4 |
Microsoft
MSFT
|
+$832M |
| 5 |
Privia Health
PRVA
|
+$655M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.24% |
| 2 | Financials | 8.33% |
| 3 | Healthcare | 8.04% |
| 4 | Consumer Discretionary | 7.57% |
| 5 | Industrials | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Outset Medical
OM
$95.3M
| $2.26M | ﹤0.01% |
6,878
-1,177
| -15% | -$359K |
|
|
SLN
3727
Silence Therapeutics
SLN
$525M
| $2.25M | ﹤0.01% |
410,000
-250,000
| -38% | -$1.51M |
|
|
EMBJ
3728
Embraer S.A. ADS
EMBJ
$12.9B
| $2.25M | ﹤0.01% |
145,627
-290,323
| -67% | -$4.42M |
|
3729
CALL
Louisiana-Pacific
LPX
$5.2B
| $2.25M | ﹤0.01% |
30,000
| – | – |
|
3730
iRadimed
IRMD
$1.17B
| $2.24M | ﹤0.01% |
46,967
-1,638
| -3% | -$73.9K |
|
3731
United Fire Group
UFCS
$1.39B
| $2.24M | ﹤0.01% |
98,896
+1,150
| +1% | +$28.4K |
|
3732
Coherus Oncology
CHRS
$230M
| $2.24M | ﹤0.01% |
524,561
-152,469
| -23% | -$900K |
|
3733
Simplify Interest Rate Hedge ETF
PFIX
$178M
| $2.24M | ﹤0.01% |
35,672
-4,406
| -11% | -$282K |
|
3734
CoreCivic
CXW
$3.19B
| $2.24M | ﹤0.01% |
237,610
-37,596
| -14% | -$341K |
|
3735
Turning Point Brands
TPB
$1.66B
| $2.23M | ﹤0.01% |
93,053
-7,190
| -7% | -$162K |
|
3736
Covenant Logistics
CVLG
$905M
| $2.23M | ﹤0.01% |
101,546
-10,892
| -10% | -$210K |
|
3737
CALL
Papa John's
PZZA
$1.01B
| $2.22M | ﹤0.01% |
+30,100
| New | +$2.23M |
|
3738
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.28B
| $2.22M | ﹤0.01% |
24,135
+6,005
| +33% | +$551K |
|
3739
Sprott Uranium Miners ETF
URNM
$1.92B
| $2.22M | ﹤0.01% |
66,016
-10,341
| -14% | -$327K |
|
3740
Phathom Pharmaceuticals
PHAT
$697M
| $2.21M | ﹤0.01% |
154,668
+105,987
| +218% | +$1.22M |
|
3741
Vanguard Industrials ETF
VIS
$8.49B
| $2.21M | ﹤0.01% |
10,743
-33,073
| -75% | -$6.32M |
|
3742
Simulations Plus
SLP
$371M
| $2.21M | ﹤0.01% |
50,946
+7,980
| +19% | +$349K |
|
3743
TriMas Corp
TRS
$1.47B
| $2.2M | ﹤0.01% |
80,057
+2,158
| +3% | +$57K |
|
3744
Capital City Bank Group
CCBG
$901M
| $2.2M | ﹤0.01% |
71,756
-13,422
| -16% | -$406K |
|
3745
JFrog
FROG
$10.6B
| $2.2M | ﹤0.01% |
79,367
-764,861
| -91% | -$17.5M |
|
3746
NETGEAR
NTGR
$648M
| $2.2M | ﹤0.01% |
155,112
+74,413
| +92% | +$1.12M |
|
3747
First Trust Cloud Computing ETF
SKYY
$3.08B
| $2.2M | ﹤0.01% |
+28,915
| New | +$1.99M |
|
3748
AMC Global Media
AMCX
$516M
| $2.19M | ﹤0.01% |
183,613
+56,014
| +44% | +$808K |
|
3749
Peloton Interactive
PTON
$2.83B
| $2.19M | ﹤0.01% |
284,980
-115,596
| -29% | -$982K |
|
|
EQRX
3750
DELISTED
EQRx, Inc. Common Stock
EQRX
| $2.19M | ﹤0.01% |
1,177,426
-750,386
| -39% | -$1.34M |
|
Similar funds
Goldman Sachs's Q2 2023 Portfolio in Review
As of Q2 2023, Goldman Sachs held 6,313 positions worth $466B, up 7.1% from $435B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs's Q2 2023 filing shows 443 new, 2,419 increased, 2,272 reduced and 593 closed positions. Its largest new stake was Pelagos Insurance Capital: 15,246,144 shares worth $208M. The largest sale was Invesco QQQ Trust, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Goldman Sachs's largest Q2 2023 buy was Pelagos Insurance Capital: 15,246,144 shares worth $208M.
- Goldman Sachs added most to Alphabet (Google) Class A in Q2 2023, an estimated $884M increase.
- Goldman Sachs's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.14B.
- Goldman Sachs fully exited DCP Midstream, LP in Q2 2023, selling an estimated $250M.
- Goldman Sachs's ten largest holdings make up 19% of its $466B portfolio in Q2 2023.
- Goldman Sachs opened 443 new positions and closed 593 in Q2 2023.
- Goldman Sachs's portfolio value rose 7.1% quarter-over-quarter to $466B.
Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.